Valuation UCB

Stocks

Market Closed - Euronext Bruxelles Other stock markets 16:55:00 03/07/2026 BST			5-day change	1st Jan Change
259.50 ^EUR	-1.93%		+0.39%	+8.76%

07-03	Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals	MT
06-25	US prices for new drugs fell in 2025 as fewer costly gene therapies were launched	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,947	13,973	14,969	36,464	45,333	49,399	-	-
Change	-	-26.25%	7.12%	143.6%	24.32%	8.97%	-	-
Enterprise Value (EV) ¹	19,807	15,973	17,146	37,918	45,326	49,127	47,086	44,553
Change	-	-19.36%	7.34%	121.15%	19.54%	8.39%	-4.16%	-5.38%
P/E	17.9x	33.4x	44.8x	34.3x	29.1x	28x	22x	17.6x
PBR	2.32x	1.58x	1.67x	3.64x	-	4.21x	3.61x	2.97x
PEG	-	-0.6x	-2.2x	0x	0.6x	2.1x	0.8x	0.7x
Capitalization / Revenue	3.28x	2.53x	2.85x	5.93x	5.86x	5.79x	5.13x	4.6x
EV / Revenue	3.43x	2.9x	3.26x	6.16x	5.86x	5.76x	4.89x	4.15x
EV / EBITDA	12.1x	12.7x	12.7x	25.7x	17.2x	16.9x	13.1x	10.4x
EV / EBIT	15x	23.7x	26.1x	45.4x	22.6x	21.4x	16.2x	12.3x
EV / FCF	15.6x	18.4x	38.5x	41.2x	24.6x	25.2x	18.2x	14.3x
FCF Yield	6.42%	5.43%	2.6%	2.43%	4.06%	3.97%	5.5%	7.01%
Dividend per Share ²	1.3	1.33	1.36	1.39	1.45	1.465	1.505	1.538
Rate of return	1.3%	1.81%	1.72%	0.72%	0.61%	0.56%	0.58%	0.59%
EPS ²	5.6	2.2	1.76	5.61	8.2	9.275	11.77	14.72
Distribution rate	23.2%	60.5%	77.3%	24.8%	17.7%	15.8%	12.8%	10.4%
Net sales ¹	5,777	5,517	5,252	6,152	7,741	8,534	9,635	10,747
EBITDA ¹	1,641	1,260	1,349	1,476	2,636	2,907	3,599	4,278
EBIT ¹	1,318	675	657	836	2,009	2,300	2,912	3,618
Net income ¹	1,058	418	343	1,065	1,558	1,747	2,264	2,818
Net Debt ¹	860	2,000	2,177	1,454	-7	-271.3	-2,313	-4,846
Reference price ²	100.35	73.56	78.90	192.20	238.60	259.50	259.50	259.50
Nbr of stocks (in thousands)	188,812	189,959	189,721	189,720	189,996	190,361	-	-
Announcement Date	24/02/22	22/02/23	28/02/24	27/02/25	24/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UCB	27.98x	5.76x	16.9x	0.56%	56.51B
REGENERON PHARMACEUTICALS, INC.	16.94x	3.69x	9.97x	0.6%	66.56B
SAMSUNG BIOLOGICS CO.,LTD.	35.25x	11.95x	22.63x	-.--%	42.98B
CSL LIMITED	-45.47x	3.2x	9.47x	3.37%	40.46B
BIOGEN INC.	34.9x	3.71x	11.39x	-.--%	31.91B
MODERNA, INC.	-9.24x	13.4x	-8.22x	-.--%	31.65B
INCYTE CORPORATION	16.96x	3.25x	9.83x	-.--%	23.35B
INNOVENT BIOLOGICS, INC.	55.23x	6.16x	42.67x	-.--%	19.46B
SWEDISH ORPHAN BIOVITRUM AB	26.86x	5.49x	14.73x	-.--%	17.18B
BRIDGEBIO PHARMA, INC.	-35.48x	16.45x	-50.02x	-.--%	15.12B
Average	12.39x	7.30x	7.93x	0.45%	34.52B
Weighted average by Cap.	13.33x	6.65x	10.53x	0.6%